Table 1.
Cohort A | Cohort B | Total | |
---|---|---|---|
N | 30 | 20 | 50 |
Median Age (range) | 56 (37-88) | 61 (38-81) | 56 (37-88) |
Gender | |||
Male | 19 (63%) | 11 (55%) | 30 (60%) |
Female | 11 (37%) | 9 (45% | 20 (40%) |
Ethnic Origin | |||
1 | 27 (90%) | 20 (100%) | 47 (94%) |
2 | 1 (3.3%) | 0 | 1 (2%) |
3 | 1 (3.3%) | 0 | 1 (2%) |
4 | 1 (3.3%) | 0 | 1 (2%) |
KPS | |||
70 | 3 (10%) | 2 (10%) | 5 (10%) |
80 | 12 (40% | 5 (25%) | 17 (34%) |
≥90 | 15 (50%) | 13 (65%) | 28 (56%) |
Stage | |||
3 | 3 (10%) | 0 | 3 (6%) |
4 | 27 (90%) | 20 (100%) | 47 (94%) |
Prior Surgery | 24 (80%) | 15 (75%) | 39 (78%) |
Prior XRT | 7 (23%) | 6 (30%) | 13 (26%) |
Prior chemo regimens | |||
0 | 6 (20%) | 3 (15%) | 9 (18%) |
1 | 8 (27%) | 12 (60%) | 20 (40%) |
2 | 11 (37%) | 2 (10%) | 13 (26%) |
3 | 5 (17%) | 3 (15%) | 8 (16%) |
Ethnic Origin: 1= white, Caucasian; 2= African American; 3= Hispanic; 4= Asian; KPS= Karnofsky Performance Status